COFEPRIS alert on falsified sclerosis medicine
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) issued an alert about the counterfeiting of...
Continue Reading
INSABI detects 51 companies that distribute counterfeit medicines to the health sector
The general director of the Health Institute for Welfare (INSABI), Juan Antonio Ferrer Aguilar, assured that the...
Continue Reading
COFEPRIS warns about counterfeit drugs against cancer and types 2 diabetes
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) issued an alert about the counterfeiting of...
Continue Reading